Indian Journal of Critical Care Medicine
An open access publication of ISCCM™ 
 
Users online: 37 
     Home | Login 
  About Current Issue Archive Search Instructions Online Submission Subscribe Etcetera Contact  
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2968    
    Printed166    
    Emailed2    
    PDF Downloaded310    
    Comments [Add]    

Recommend this journal

 

 CASE REPORT
Year : 2008  |  Volume : 12  |  Issue : 3  |  Page : 124--127

Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting


Department of Critical Care, Narayana Hrudayalaya Institute of Medical Sciences, 258/A, Bommasandra, Anekal Taluk, Bangalore, India

Correspondence Address:
Girish T Nagendra
254, 11th Cross, 8th Main Road, Vidyagiri Layout, Nagarabavi 1st Stage, Bangalore-560 072
India
Login to access the Email id


DOI: 10.4103/0972-5229.43681

PMID: 19742259

Get Permissions

Transfusion associated graft versus host disease (TA-GVHD) is a rare but commonly fatal complication of transfusion of cellular blood products, which usually occurs in immunosuppressed individuals following transfusion and subsequent engraftment of viable T lymphocytes. Very rarely it may arise in apparently immunocompetent individuals. The clinical syndrome consists of fever, skin rash, diarrhoea, hepatic dysfunction, and bone marrow aplasia. The outcome is nearly always fatal. We present here a case report of fatal TA-GVHD in a "presumed" immunocompetent patient, post coronary artery bypass grafting surgery after transfusion of blood products. The patient died 24 days after transfusion. There is a perceived increased risk of TA-GVHD following bypass grafting and other surgical procedures where cardiopulmonary bypass is required. TA-GVHD is probably underreported and the incidence is felt to be too low to warrant routine irradiation of cellular products for this group of patients. Clinicians, pathologists, and transfusion centers should be aware of this rare but devastating complication of blood transfusion after cardiac surgery.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 7th April '04
Published by Medknow